Sanders slams drugmakers' business practices in new report ahead of CEO hearing
A new report released Tuesday by Sen. Bernie Sanders (I-Vt.) takes aim at the prices and executive compensation of three major drug manufacturers, previewing his lines of attack for when the companies’ CEOs appear at a hearing later this week. In the report prepared by Democratic staff on the Senate Health, Education, Labor and Pensions…